Kenneth E. Goodman
Chairman at Israel Cancer Research Fund
Profile
Kenneth E.
Goodman is currently the Vice Chairman at Syracuse University and the Chairman at Israel Cancer Research Fund since 2012.
Previously, he worked as a Director at Forest Laboratories, Inc. from 1998 to 2011 and as a Senior Financial Officer at Wyeth LLC in 1980.
Mr. Goodman completed his undergraduate degree at The Martin J.
Whitman School of Management.
Kenneth E. Goodman active positions
| Companies | Position | Start |
|---|---|---|
| Syracuse University | Director/Board Member | - |
Israel Cancer Research Fund
 Israel Cancer Research Fund Investment Trusts/Mutual FundsMiscellaneous Israel Cancer Research Fund operates as a charitable organization. The non-profit company is based in New York, NY. | Chairman | - |
Former positions of Kenneth E. Goodman
| Companies | Position | End |
|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Director of Finance/CFO | 1979-12-31 |
| FOREST LABORATORIES, INC. | Director/Board Member | - |
Training of Kenneth E. Goodman
| The Martin J. Whitman School of Management | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Israel Cancer Research Fund
Israel Cancer Research Fund Investment Trusts/Mutual FundsMiscellaneous Israel Cancer Research Fund operates as a charitable organization. The non-profit company is based in New York, NY. | Miscellaneous |
- Stock Market
- Insiders
- Kenneth E. Goodman
